is tirzepatide a dual agonist and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Tirzepatide: A dual agonist for

Does GLP-1 Cause Hair Loss

"Theres a real opportunity and need to provide free nutrition guidance and content to educate a growing population of people accessing GLP-1 medications for weight loss so they have long-term, sustainable outcomes." Mike Fisher, CEO, MyFitnessPal Smart devices like wearables and scales that sync with platforms like Apple Health or Google Fit can further simplify tracking

These drugs work by mimicking the GLP-1 hormone naturally found in the body

Drinking enough water, eating smaller meals more often, and changing the dose of the medication can sometimes help reduce these side effects

Specialist consultation included

"And this has a massive impact in helping people take off weight, improve all their biomarkers